Correlation Between Aquestive Therapeutics and Radcom

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aquestive Therapeutics and Radcom at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aquestive Therapeutics and Radcom into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aquestive Therapeutics and Radcom, you can compare the effects of market volatilities on Aquestive Therapeutics and Radcom and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aquestive Therapeutics with a short position of Radcom. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aquestive Therapeutics and Radcom.

Diversification Opportunities for Aquestive Therapeutics and Radcom

0.12
  Correlation Coefficient

Average diversification

The 3 months correlation between Aquestive and Radcom is 0.12. Overlapping area represents the amount of risk that can be diversified away by holding Aquestive Therapeutics and Radcom in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Radcom and Aquestive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aquestive Therapeutics are associated (or correlated) with Radcom. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Radcom has no effect on the direction of Aquestive Therapeutics i.e., Aquestive Therapeutics and Radcom go up and down completely randomly.

Pair Corralation between Aquestive Therapeutics and Radcom

Given the investment horizon of 90 days Aquestive Therapeutics is expected to under-perform the Radcom. In addition to that, Aquestive Therapeutics is 1.19 times more volatile than Radcom. It trades about -0.12 of its total potential returns per unit of risk. Radcom is currently generating about 0.2 per unit of volatility. If you would invest  1,008  in Radcom on August 27, 2024 and sell it today you would earn a total of  154.00  from holding Radcom or generate 15.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Aquestive Therapeutics  vs.  Radcom

 Performance 
       Timeline  
Aquestive Therapeutics 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Aquestive Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Aquestive Therapeutics is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.
Radcom 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Radcom are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak fundamental indicators, Radcom displayed solid returns over the last few months and may actually be approaching a breakup point.

Aquestive Therapeutics and Radcom Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aquestive Therapeutics and Radcom

The main advantage of trading using opposite Aquestive Therapeutics and Radcom positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aquestive Therapeutics position performs unexpectedly, Radcom can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Radcom will offset losses from the drop in Radcom's long position.
The idea behind Aquestive Therapeutics and Radcom pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities